The latest news, stories and exciting findings from across the Oxford cancer research community
Oxford to assess revolutionary multi-cancer blood test in trial, for future implementation in the NHS
15 September 2021
A partnership between the University of Oxford and GRAIL, LLC will evaluate the use of a new, non-invasive, multi-cancer early detection test known as Galleri in suspected cancer patients.
Oxford Cancer Analytics awarded £1.27M to revolutonise lung cancer management
10 September 2021
OXcan, an Oxford University spin out, has raised money to apply their machine learning approach to lung cancer early detection
Vaccine for treating cancer made possible using Oxford COVID vaccine technology
3 September 2021
A new publication from Benoit Van den Eynde's group has shown that a viral vector cancer vaccine generates effective anti-tumour immune responses and, in combination with immunotherapy, decreases tumour size and increases survival rates in mouse models.
Oxford’s cancer-risk research featured in special edition of PLOS Medicine focussed on advances in early cancer detection
2 September 2021
Research from Dr Brian Nicholson and colleagues outlines how routine clinical tests could be widely used to estimate the risk of cancer for people visiting their GPs with unexpected weight loss.
World Chronic Lymphoid Leukaemia Day 2021
1 September 2021
Researchers from Oxford University and OUH are joining celebrations for the first world CLL day on 1 September 2021.
Two Oxford immunotherapy research projects awarded funding by Prostate Cancer UK
31 August 2021
Prostate Cancer UK have invested £1.7 million into five immunotherapy projects, including two from Profs Kate Vallis, Richard Bryant and Eileen Parkes at the University of Oxford. Read about their funded work.
Oxford spin out partners with J&J to transform lung cancer treatment
18 August 2021
Optellum, a lung health start-up in Oxford, aims to redefine early interception of lung cancer using artificial intelligence (AI) decision support software.
NCITA Publishes Comment Article in the British Journal of Cancer
16 August 2021
Read their introduction to the National Cancer Imaging Translational Accelerator (NCITA): a UK-wide infrastructure for multicentre clinical translation of cancer imaging biomarkers.
First patient dosed with drug designed to re-sensitise patients to cancer treatment
5 August 2021
The first patient has been dosed using new drug PORT-2 in Oxford, which hopes to improve treatment options for melanoma and Non-Small Cell Lung Cancer (NSCLC) and resensitise patients with checkpoint therapy-resistant tumours
Mechanism behind repair of cancer-inducing mutations discovered
28 July 2021
New research from Ross Chapman’s lab has discovered the precise mechanism behind how the BRCA1 protein detects and engages with DNA breaks in the genome, helping to prevent the development of breast and ovarian cancers.
Oxford Cancer – behind the brand
27 July 2021
Our new brand represents how Oxford researchers are working across disciplines to translate their discoveries into better care for cancer patients. Meet the new brand and the people behind it.
AI software to help clinicians diagnose lung cancer earlier and reduce patient waiting lists
26 July 2021
A new artificial intelligence software that will help doctors to make quicker and more accurate decisions when diagnosing potentially cancerous lung lesions, has received major government funding.
Protein structure solution paves way for improved anti-cancer drugs
16 July 2021
A new study from the Newstead group at the Department of Biochemistry has solved the structure of the human folate transporter, paving the way for improved anticancer drugs.
New network Oxford Cancer launches
14 July 2021
A new pan-divisional initiative has launched at the University of Oxford. Bringing together the collective force of cancer research, outreach and care that happen across the city of Oxford.
The next step in personalised cancer medicine
6 July 2021
Botnar Research Centre researchers have developed standalone long-read sequencing of single cells technology that could open new avenues into the causes of diseases like cancer.
Oxford Cancer welcomes Professor Stefan Constantinescu
5 July 2021
Professor Stefan Constantinescu joins Ludwig Oxford to expand his research programme in cancer epigenetics.
Study investigating targeted drug delivery by focused ultrasound for pancreatic cancer opens
2 July 2021
University of Oxford researchers have begun recruitment to a study looking at whether chemotherapy medication can reach pancreatic tumours more effectively if encapsulated within a heat-sensitive shell and triggered with focused ultrasound.
14 new CRUK Oxford Centre Development Fund Awardees
1 July 2021
The awardees from the 2021 round of the CRUK Oxford Centre Development fund have been announced. Read about what research they will be undertaking.
Oxford wins government funding to evaluate prostate cancer detection system
24 June 2021
A prostate cancer detection software system to help pathologists quickly identify suspicious areas of tissue, developed by Paige, will be investigated in a multicentre clinical study led by Oxford University.
Two clinical academic research partnerships awarded to Oxford researchers
22 June 2021
Congratulations to Dr Karthik Ramasamy & Dr John Jacob on their CARP awards from the Medical Research Council. Find more about their work that is being funded.